GGHSX Holdings Information

GGHSX is a mutual fund with a total of 79 individual holdings. The top holdings are Eli Lilly and Company stock at 10.43%, Johnson & Johnson at 6.04%, UnitedHealth Group at 5.73%, Gilead Sciences at 3.97%, and argenx SE at 3.88%.

Total Holdings

Top 10 Percentage

45.68%

Asset Class

Equity

Fund Category

Health

Assets

1.23B

Forward PE Ratio

20.56

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	10.43%	107,822
2	JNJ	Johnson & Johnson	6.04%	306,494
3	UNH	UnitedHealth Group Incorporated	5.73%	172,099
4	GILD	Gilead Sciences, Inc.	3.97%	337,004
5	ARGX	argenx SE	3.88%	52,976
6	ABBV	AbbVie Inc.	3.69%	193,684
7	MRK	Merck & Co., Inc.	3.38%	325,166
8	LON: AZN	AstraZeneca PLC	3.37%	207,249
9	BTSG	BrightSpring Health Services, Inc.	2.60%	482,157
10	MCK	McKesson Corporation	2.60%	40,033
11	WELL	Welltower Inc.	2.16%	120,441
12	RPRX	Royalty Pharma plc	2.15%	440,990
13	CVS	CVS Health Corporation	2.09%	262,103
14	TRPXX	Short-Term Investment Trust - Invesco Treasury Portfolio	2.02%	23,068,261
15	VRTX	Vertex Pharmaceuticals Incorporated	2.00%	50,958
16	CAH	Cardinal Health, Inc.	1.90%	110,152
17	AXSM	Axsome Therapeutics, Inc.	1.80%	87,700
18	GH	Guardant Health, Inc.	1.73%	152,178
19	EBR: UCB	UCB SA	1.50%	58,259
20	EW	Edwards Lifesciences Corporation	1.46%	192,738
21	REGN	Regeneron Pharmaceuticals, Inc.	1.44%	26,693
22	BBIO	BridgeBio Pharma, Inc.	1.25%	216,227
23	SWX: SDZ	Sandoz Group AG	1.25%	169,209
24	IDXX	IDEXX Laboratories, Inc.	1.16%	23,511
25	ISRG	Intuitive Surgical, Inc.	1.14%	30,687

Showing 25 of 79 holdings

Subscribe to see the full list

Activate Now

As of May 31, 2026